9 C
New York
Monday, December 4, 2023

There’s No Need To Panic Or Freeze When It Comes To Acadia Pharmaceuticals Inc (NASDAQ: ACAD)

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. After-hours trades for Acadia Pharmaceuticals Inc (ACAD) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.46, or 2.01%, to $23.38. The Acadia Pharmaceuticals Inc has recorded 23,380 volume in the after hours trading session. The stock was recently discussed on Yahoo Finance as it revealed that Acadia Pharmaceuticals to Participate in the Guggenheim Securities 5th Annual Inflammation & Immunology Conference.

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


Stocks Info

The company is listed on the NASDAQ and operates within the Biotechnology industry segment. At the end of the last regular session, the stock closed at $22.92 and fluctuated between $23.00 as its day high and $22.35 as its day low. The current market capitalization of Acadia Pharmaceuticals Inc is $3.75B. A total of 1.6 million shares were traded on the day, compared to an average of 1.61M shares.

Insider Activity

Furthermore, investors take into consideration insider trades when predicting a stock’s future trajectory. During the recent three months, ACAD has seen 0 BUY and 2 SELL insider trades, representing the acquisition of 0 and the disposition of 12,000 shares. Over the last 12 months, there were 42 BUYs and 27 SELLs from insiders. Insiders purchased 710,438 shares during that period but sold 267,545.

In the most recent transaction, DAVIS STEPHEN sold 51,563 shares of ACAD for 21.96 per share on Oct 06. After the transaction, the CEO now owns 89,131 company shares. In a previous transaction on Oct 06, KIM AUSTIN D. sold 16,369 shares at 21.96 per share. ACAD shares that EVP,General Counsel, Secretary owns now total 45,857.

Among the insiders who sold shares, Kihara James disposed of 2,000 shares on Sep 15 at a per-share price of $25.88. This resulted in the Principal Accounting Officer holding 10,778 shares of ACAD after the transaction. In another insider transaction, Schneyer Mark C. sold 10,000 shares at $29.00 per share on Aug 21. Company shares held by the EVP, Chief Financial Officer now total 15,682.

It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. According to analysts who have offered 12-month price targets for ACAD in the last 3 months, the mean price target is $32.00 with high estimates of $42.00 and low estimates of $13.00. In terms of 52-week highs and lows, ACAD has a high of $33.99 and a low of $13.73.

As of this writing, ACAD has an earnings estimate of -$0.43 per share for the current quarter. EPS was calculated based on a consensus of 18 estimates, with a high estimate of -$0.05 per share and a lower estimate of -$0.68. The company reported an EPS of -$0.27 in the last quarter, which was -28.60% lower than expectations of -$0.21.

Balance Sheet Annually/Quarterly

An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. ACAD’s latest balance sheet shows that the firm has $520.71M in Cash & Short Term Investments as of fiscal 2021. There were $56.13M in debt and $96.07M in liabilities at the time. Its Book Value Per Share was $2.42, while its Total Shareholder’s Equity was $540.89M.

Analysts Opinion

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ACAD is Buy with a score of 4.00.

Related Articles


Please enter your comment!
Please enter your name here

Latest Articles